CJC-1295 + Ipamorelin Dosage Guide

CJC-1295 and Ipamorelin stimulate growth hormone release through two different but complementary receptors. CJC-1295 is a GHRH analogue that primes the pituitary for GH release; Ipamorelin is a selective GHRP that triggers the actual pulse — without significantly affecting cortisol or prolactin in animal studies, unlike older GHRPs such as GHRP-6. Studies of GHRH–GHRP combinations report larger GH pulses than either compound alone. Neither compound is FDA-approved; the amounts in this guide are reference figures commonly discussed in research communities, not medical recommendations. The most-cited reference amount is 300mcg CJC-1295 + 200mcg Ipamorelin per injection, 1–3 times daily, taken fasted. Both come from 5mg vials; with 2ml BAC water each (2500 mcg/ml), 300mcg = 12 units and 200mcg = 8 units.

Key Takeaways

• Commonly discussed amounts: CJC-1295 (100-200 mcg) + Ipamorelin (100-300 mcg) per injection, 1-3 times daily
• Injection timing: discussed for use on an empty stomach, 30 minutes before meals or 2 hours after
• Cycle durations discussed: 8-12 weeks with 4-6 week breaks, in community references
• Administration method: Subcutaneous injection is the preferred delivery method
• Individual variation: discussed amounts vary with individual response and tolerance
• Professional guidance: Medical supervision is recommended for optimal results and safety

Use the CJC-1295 + Ipamorelin Dosage Calculator for exact injection volumes.

Understanding CJC-1295 and Ipamorelin

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce more growth hormone. Ipamorelin is a growth hormone secretagogue (GHS) that works synergistically with CJC-1295 to enhance growth hormone release — the cortisol/prolactin selectivity was documented in animal research.

When combined, the two target complementary pathways of GH release. Effects downstream of GH — body composition, sleep quality, recovery — are drawn mostly from user reports rather than controlled trials.

Why Combine CJC-1295 and Ipamorelin?

The combination approach offers several advantages over using either peptide individually:

• Enhanced effectiveness: The two peptides work through different pathways, maximizing growth hormone release
• Sustained release: CJC-1295 provides longer-lasting effects while Ipamorelin offers immediate stimulation
• Reduced side effects: Lower individual doses are needed when combined
• Improved compliance: Fewer total injections compared to higher single-peptide protocols

Commonly Discussed Amount Ranges

Low-End Reference

The lowest amounts commonly discussed, useful as a reference floor:

CJC-1295: 100 mcg per injection Ipamorelin: 100-150 mcg per injection Frequency: Once daily, preferably before bedtime Duration: 6-8 weeks

Mid-Range Reference

Amounts in the middle of the discussed range:

CJC-1295: 150-200 mcg per injection Ipamorelin: 200-250 mcg per injection Frequency: Twice daily (morning and evening) Duration: 8-10 weeks

Upper-Range Reference

The highest amounts and frequencies commonly discussed:

CJC-1295: 200 mcg per injection Ipamorelin: 250-300 mcg per injection Frequency: Three times daily Duration: 10-12 weeks

Amounts Discussed in Physique and Performance Contexts

In bodybuilding communities, the amounts discussed overlap with the ranges above; they are listed here as reference figures only.

Contest-Prep References

Figure sets discussed for contest prep (12-16 weeks out):

• CJC-1295: 200 mcg
• Ipamorelin: 300 mcg
• Frequency: 3 times daily
• Timing: Upon waking, pre-workout, and before bed

Peak-week variations discussed:

• Reduced to twice daily over water-retention concerns
• Timing kept consistent

Off-Season References

Amounts discussed for muscle-building phases:

• CJC-1295: 150-200 mcg
• Ipamorelin: 200-250 mcg
• Frequency: 2-3 times daily
• Timing discussed: post-workout and bedtime

Step-by-Step Administration Guide

Preparation Steps

1. Gather supplies: Peptide vials, bacteriostatic water, insulin syringes, alcohol swabs
2. Reconstitution: Mix peptides with appropriate amount of bacteriostatic water
3. Storage: Keep reconstituted peptides refrigerated at 2-8°C
4. Hygiene: Ensure clean workspace and sterile technique

Injection Protocol

1. Site selection: Rotate between subcutaneous sites (abdomen, thigh, arm)
2. Preparation: Clean injection site with alcohol swab
3. Drawing medication: Use insulin syringe to draw precise dosage
4. Injection technique: Pinch skin, insert needle at 45-degree angle
5. Post-injection: Apply gentle pressure, dispose of materials safely

Timing Optimization

Morning dose (if applicable):

• Discussed timing: upon waking, fasted
• 30 minutes before eating

Pre-workout dose:

• Discussed timing: 15-30 minutes before training
• Rationale given: GH response around training

Evening dose:

• Discussed timing: 2-3 hours after the last meal
• Rationale given: aligning with natural overnight GH release

Factors Affecting Dosage Requirements

Individual Variables

Age: Natural GH production declines with age, which is one reason use in older populations is discussed.

Body weight: Some discussions scale amounts with body weight.

Training intensity: Training frequency changes how many daily injections some schedules use.

Goals: Discussed amounts differ between fat-loss and muscle-gain contexts.

Response Monitoring

User discussions commonly cite the following as indicators people monitor:

• Sleep quality improvements
• Recovery between training sessions
• Body composition changes
• Energy levels throughout the day
• Any adverse reactions

Safety Considerations and Side Effects

Common Side Effects

Most users tolerate the CJC-1295 and Ipamorelin combination well, but potential side effects include:

• Injection site reactions (redness, swelling)
• Temporary flushing
• Mild headaches
• Increased hunger
• Slight water retention

Contraindications

Avoid use if you have:

• Active cancer or history of malignancy
• Severe cardiac conditions
• Pregnancy or breastfeeding
• Uncontrolled diabetes

Commonly Suggested Precautions

• Community discussions suggest starting below the reference ranges to gauge tolerance
• Rotate injection sites regularly
• Maintain proper hydration
• Monitor blood glucose levels if diabetic
• Schedule regular health check-ups

Using a CJC-1295 Ipamorelin Dosage Calculator

A CJC-1295/ipamorelin calculator handles the conversion math rather than recommending amounts — it turns a vial size, BAC water volume, and target amount into syringe units. Inputs typically include:

• Vial size and BAC water volume
• Target amount per injection
• Syringe type (100-unit insulin syringe)
• Desired injection frequency

Benefits of using a dosage calculator include:

• Fewer calculation errors
• Consistent reconstitution ratios
• Injection volume checks

Cycling and Long-Term Use

Cycle Structure in Community References

On-cycle duration: 8-12 weeks Off-cycle duration: 4-6 weeks Annual cycles: 2-3 per year, a self-imposed ceiling in those discussions

Cycle Support

During active cycles:

• Monitor biomarkers through blood work
• Maintain consistent sleep schedule
• Follow structured training program
• Optimize nutrition for goals

Post-Cycle Considerations

After completing a cycle:

• Allow natural hormone production to normalize
• Maintain training and nutrition consistency
• Assess results and adjust future protocols
• Consider health marker evaluation

Frequently Asked Questions

How long does it take to see results from CJC-1295 and Ipamorelin?

Most users report initial improvements in sleep quality and recovery within 2-3 weeks. Visible body composition changes typically become apparent after 6-8 weeks of consistent use. User reports describe the most noticeable changes around the 12-week mark.

Can I take CJC-1295 and Ipamorelin together in the same injection?

Yes, these peptides can be combined in the same syringe and administered as a single injection. This approach is convenient and doesn’t reduce the effectiveness of either compound. Ensure both peptides are properly reconstituted before mixing.

What’s the difference between CJC-1295 DAC and CJC-1295 no-DAC when combined with Ipamorelin?

CJC-1295 with DAC has a half-life of roughly 6–8 days and is discussed at schedules of once to twice weekly, while CJC-1295 no-DAC (half-life about 30 minutes) is discussed for daily or twice-daily schedules. When combined with Ipamorelin, no-DAC is often preferred as it allows for more precise timing and better mimics natural growth hormone release patterns.

Should I adjust my dosage based on training days vs. rest days?

Many users maintain consistent daily dosing regardless of training status. However, some protocols involve slightly higher doses on training days or timing injections around workouts. The key is maintaining consistency in your chosen approach rather than frequently changing dosages.

What should I do if I miss a dose?

Common guidance is to resume the normal schedule rather than doubling up — a doubled injection produces concentrations well above the intended reference range. Consistency matters more than perfection, and occasional missed doses are not described as significantly affecting overall results.

Use our CJC-1295 Ipamorelin dosage calculator to convert these reference amounts into concentrations and syringe units for any vial size and BAC water volume.